文献速递口腔修复与种植牙周病

CCR2是种植体周炎潜在治疗靶点

CCR2 is a potential therapeutic target in peri-implantitis.
PubMed 文献 · J Clin Periodontol · 2023-12-18

本研究探讨CCR2在种植体周炎中的作用及cenicriviroc(CVC)的治疗效果。人种植体周炎组织CCR2和CCL2水平升高且与骨丧失正相关;Ccr2敲除小鼠单核/巨噬细胞浸润、促炎因子和破骨细胞活性降低,骨丧失减少;CVC治疗改善实验性种植体周炎骨丧失。

要点

  • 人种植体周炎组织中CCR2和CCL2水平升高,与种植体周围骨丧失正相关。
  • 敲除Ccr2可减少单核/巨噬细胞浸润、促炎因子生成和破骨细胞活性,减轻炎症与骨丧失。
  • CVC(全身和局部剂型)可改善实验性种植体周炎的骨丧失。

核心结论

  • CCR2可能通过调控免疫炎症反应影响局部炎症和破骨细胞活性,是种植体周炎的潜在治疗靶点。

研究设计与样本

  • 结合临床组织分析与体内种植体周炎模型,并在Ccr2-/-小鼠与野生型小鼠中评估CCR2作用。
  • 使用全身和局部剂型的CVC评估其对实验性种植体周炎的治疗效果。

主要发现

  • 人种植体周炎组织中CCR2和CCL2水平升高,且与种植体周围骨丧失呈正相关。
  • 实验性种植体周炎模型中敲除Ccr2后,单核细胞和巨噬细胞浸润减少、促炎细胞因子生成降低、破骨细胞活性受损,种植体周围炎症和骨丧失减少。
  • CVC治疗改善了实验性种植体周炎的骨丧失。

临床怎么用

  • CCR2/CCL2轴可作为种植体周炎免疫炎症干预的潜在靶点。
  • CVC在实验模型中显示减轻种植体周炎骨丧失的作用,尚需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: CCR2 (C-C chemokine receptor type 2) plays a crucial role in inflammatory and bone metabolic diseases; however, its role in peri-implantitis remains unclear. This study aimed to explore whether CCR2 contributes to peri-implantitis and the treatment effects of cenicriviroc (CVC) on peri-implant inflammation and bone resorption. MATERIALS AND METHODS: The expression of CCR2 was studied using clinical tissue analysis and an in vivo peri-implantitis model. The role of CCR2 in promoting inflammation and bone resorption in peri-implantitis was evaluated in Ccr2-/- mice and wild-type mice. The effect of CVC on peri-implantitis was evaluated using systemic and local dosage forms. RESULTS: Human peri-implantitis tissues showed increased CCR2 and CCL2 levels, which were positively correlated with bone loss around the implants. Knocking out Ccr2 in an experimental model of peri-implantitis resulted in decreased monocyte and macrophage infiltration, reduced pro-inflammatory cytokine generation and impaired osteoclast activity, leading to reduced inflammation and bone loss around the implants. Treatment with CVC ameliorated bone loss in experimental peri-implantitis. CONCLUSIONS: CCR2 may be a potential target for peri-implantitis treatment by harnessing the immune-inflammatory response to modulate the local inflammation and osteoclast activity.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Yuan S, Wei Y, Jiang W, et al. CCR2 is a potential therapeutic target in peri-implantitis. J Clin Periodontol. 2023. PMID: 38111083. doi:10.1111/jcpe.13916

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。